Roman Dahl

Co-Founder @ The Rapid Reset. MD @ Aeonda Partners. Executive Coach & Leadership Advisor. Formerly @ DeepMind, Google, Atai Life Sciences, McKinsey & BCG

[Roman Dahl @Roman_Dahl]

@ch402 Well said and thanks for showing up and speaking clearly on this topic. Much needed in the current climate of wild swings between AI hype and doomerism.

[Roman Dahl @Roman_Dahl]

What an unlikely alliance. Such profound and true words though. Encouraging to see those building (or rather “growing”) this new species being intricately concerned with its societal impact. The only way to truly build great AI that benefits humanity as a whole and at large!

[Anthropic @AnthropicAI]

Anthropic co-founder Chris Olah was invited to speak at today's presentation of Pope Leo XIV's encyclical "Magnifica humanitas."

Read the full text of his remarks: https://t.co/CoBfkVOVcy

[Roman Dahl @Roman_Dahl]

@ValerioCapraro This is exactly why the AGI debate is often not helpful and misses the bigger picture. @DarioAmodei often talks about “powerful AI” (see his essays for a definition) which I think is way more useful right now.

[Roman Dahl @Roman_Dahl]

@lennysan @danshipper #6 is real! And it’s partly why big SaaS isn’t going anywhere (see also #5). Most people just want things that work out of the box. Personalization and adaptation to their personal context? Yes please! But constant building, deploying, integrating, updating, and so on? No thanks!

[Roman Dahl @Roman_Dahl]

@santifer Incredible repo. Highly recommend to anyone looking for a job in this crazy and ever-changing market. One of the best use cases nd implementations for agentic AI in the personal realm I've seen

[Michael Pollan @michaelpollan]

Worth your while: Ketamine Therapy Is Going Mainstream. Are We Ready? | The New Yorker https://t.co/DfkPmsaPpB

[Roman Dahl @Roman_Dahl]

Happy New Year! All the best to you, your friends and family!

[Srinivas G. Rao @SriniGRao]

We’re so impressed by the @COMPASSPathway #COMP360 P2b #psilocybin TRD data that we’re raising our stake to 20.8%. Proud to make such a public show of confidence in the company, data, clinical programs & its future in #mentalhealth.

See: https://t.co/tzUp3VvCRx

[AtaiBeckley Inc @ataibeckley]

Today we announced our Q3 financials & corporate update. Proud to highlight our latest achievements across our 11 programs, including 2 new trials, 1 key readout in COMP360, promising interim RL-007 data & launch of atai Impact #mentalhealth #innovation

https://t.co/oN64dAABhj

[Florian Brand @flobrand]

We’re driving accelerated timelines for our compound RL-007, for Cognitive Impairment Associated with Schizophrenia, given promising interim Phase 2a data, with Recognify.

Press release: https://t.co/BAdyuTXIZ8

#schizophrenia #researchanddevelopment

[James Peyer @JamesPeyer]

We raised another $100M to create new medicines targeting the causes of aging!

Our secret plan to use existing regulatory pathways and the incredible biology of #longevity to build drugs that extend #healthspan is kicking into high gear

https://t.co/bGyIkoLSJW

[Christian Angermayer @C_Angermayer]

What #DuneMovie teaches us about mental health

@atai_life $ATAI $CMPS #psychedelics #Dune

https://t.co/MRzPU5mruQ

[Robin Carhart-Harris @RCarhartHarris]

Agreed. Better to legalise regulated psilocybin therapy - as per Oregon model (IMHO).

[Florian Brand @flobrand]

Promising indications today from @MDCancerCare’s preliminary open-label Phase II data on #psilocybin (COMP360) in #cancer patients with MDD. Looking forward to the final data readout. The @atai_life portfolio keeps getting stronger!

#mentalhealth $ATAI

https://t.co/uyPqW7likN

[Microdose Psychedelic Insights @MicrodoseHQ]

.@atai_life Launches new Philanthropic Program: atai Impact

$ATAI @FloBrand #psychedelics #drugdevelopment #mentalhealth #psychedelics
.

https://t.co/spIT7dei2Q

[Mornings with Maria @MorningsMaria]

.@atai_life founder @C_Angermayer tells @MariaBartiromo that psychedelics may be the "biggest potential" mental health innovation.

Angermayer discusses his company's goal to transform mental health treatment using psychedelic compounds.

[AtaiBeckley Inc @ataibeckley]

Our Co-Founder & Chairman @C_Angermayer, is again center stage - at @MilkenInstitute Global Conference - raising the critical topic of #psychedelics & our data-driven approach to exploring their potential in easing the global #mentalhealth and #addiction crises.

#MIGlobal $ATAI

[Roman Dahl @Roman_Dahl]

@SteveBartlettSC Congrats @SteveBartlettSC. Well deserved!

[End Well @endwellproject]

The future of #psychedelic therapies will depend in a large part on the avenues by which these treatments are brought to market. A great panel happening on “Different Lenses on Psychedelics” w/ @ndrewlee @FilamentHealth @atai_life’s @SriniGRao, Dr. Victoria Hale. #TheEndInMind

[AtaiBeckley Inc @ataibeckley]

What is precision psychiatry? Therapy for a mental health disorder targeted to an individual’s specific needs. An emerging field which aims to treat & prevent disorders by factoring each patient’s variability in genes, environment, and lifestyle.
#PrecisionPsychiatry $ATAI